President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S.

There’s so much to detest about the president of the United States, but setting his targets on the pharmaceutical industry might actually turn out to be beneficial for citizens. Maybe.

I’m sure this executive order, like most of his, will be challenged (and rightfully so). His motivation is clearly focused on the US budget rather than benefiting citizens struggling with healthcare costs. However, I wonder if this might actually get the ball rolling with some much much needed reform. One can hope?

  • ⓝⓞ🅞🅝🅔OPEnglish
    3·
    12 days ago

    Precisely my thought as well. In the long run, the order alone won’t amount to anything. It needs to be followed up. Not simply by other executive orders, but by other necessary reforms.

    I guess I’m mostly interested and hopeful in the possible reform portion. The industry simply can’t be bludgeoned into compliance as he thinks he can achieve with everything. It will take careful planning, reorganization, and, gasp, additional controls and regulations.